Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-674-6 | CAS number: 109-46-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Carcinogenicity
Administrative data
- Endpoint:
- carcinogenicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 978
- Report date:
- 1978
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Study was performed to determine whether selected chemicals have the capacity to produce cancer in animals. Mice were exposed to DETU in diet during 103 weeks.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- 1,3-diethyl-2-thiourea
- EC Number:
- 203-308-5
- EC Name:
- 1,3-diethyl-2-thiourea
- Cas Number:
- 105-55-5
- Molecular formula:
- C5H12N2S
- IUPAC Name:
- 1,3-diethylthiourea
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River breeding Laboratories, Inc., Wilmington, Massachussets
- Age at study initiation: around 6 weeks-old
- Weight at study initiation: no data
- Fasting period before study: no data
- Housing: in polycarbonate cages suspended from aluminium racks.
- Diet (e.g. ad libitum): Wayne Lab-Blox (Allied Mills, Inc. Chicago, Ill.), ad libitum
- Water (e.g. ad libitum): aciduled water (pH 2.5) was suplied to animals in water bottles filled in an automated metering device, ad libitum
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-26°C
- Humidity (%):45-55%
- Air changes (per hr):12-15
- Photoperiod (hrs dark / hrs light): fluorescent lighlting 8h/day (9.00 am to 5.00 pm)
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- - Concentration: 250 and 500 ppm.
- Positive control: non - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 103 weeks
- Frequency of treatment:
- daily
- Post exposure period:
- 1 week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 ppm
- Dose / conc.:
- 250 ppm
- No. of animals per sex per dose:
- - Number of animals per dose: 50 males + 50 females
- Control groups: 20 males + 19 females - Control animals:
- yes, concurrent no treatment
- Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- - Body weight: immediately prior to initiation of the experiment and then once monthly throughout the bioassay
- Food consumption: collected at monthly intervals from 20 of the animals of the animals in each group.
- Mortality: inspected twice daily - Sacrifice and pathology:
- - Animal sacrifice: by CO2 asphyxiation, at the end of the bioassay or when moribund or when animals developed large, palpable masses that jeopardize their health.
- Necropsy: as soon as death occured.
- Gross and microscopic examination of all major tissues, organs and gross lesions.
- Tissues were preserved in a 10 percent neutral buffered formalin solution, embedded in paraffin, sectioned, and stained with hematoxylin and eosin prior to microscopic examination. Slides were prepared from the following tissues: skin, subcutaneous tissue, lungs and bronchi, trachea, bone marrow, spleen, lymph nodes, thymus, heart, salivary gland, liver, pancreas, esophagus, stomach, small intestine, large intestine, kidney, urinary bladder, pituitary, adrenal, thyroid, parathyroid, testis, prostate, brain, tunica vaginalis, uterus, mammary gland and ovary. - A few tissues were not examined for some animals, particularly for those that died early. Besides, some animals were missing, cannibalized, or judged to be in such an advanced state of autolysis as to preclude histopathologic interpretation. - Statistics:
- - A Tarone test was performed to evaluate association between dosage and mortality. - Statistical analyses for a possible dose-related effect on survival used the method of Cox (1972) when testing two groups for equality and used Tarone's (1975) extensions of Cox's methods when testing a dose-related trend.
- To determine whether animals receiving the test substance developed a significantly higher proportion of tumors than did the control animals, the one-tailed Fisher exact test was used to compare the tumor incidence of a control group to that of a group of treated animals at each dose level. In practice, the incidence of lesions was analyzed by a Cochran-Armitage test which was used when comparing the dosed groups to the control and which was supported by a Fisher exact test, comparing the high dose group to the control.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No abnormal clinical signs were recorded.
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- no mortality observed
- Description (incidence):
- There were no significant positive associations between the dosages of N,N'-diethylthiourea administered and mortality of either sex.
There were adequate numbers of animals in all dose groups survived sufficiently long to be at risk from late-developing tumors. - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Dose related mean body weight depression was apparent in both male and female mice after week 30, indicating that the concentrations of N,N'-diethylthiourea administered to mice may have approximated the maximum tolerated dosages (250 and 500 ppm)..
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- The severity and incidence of non-neoplastic lesions were also not unusual (ex: pneumonia, spleen hyperplasia...).
- Histopathological findings: neoplastic:
- no effects observed
- Description (incidence and severity):
- In both sexes, the neoplasms observed were similar in type and distribution in dosed and control mice (ex: alveolar/bronchiolar adenoma, hepatocellular adenoma and carcinoma, leukemia or malignant lymphoma...). None of statistical tests for any site revealed a significant positive association between administration of compound and increased tumor incidence.
- Other effects:
- not examined
- Relevance of carcinogenic effects / potential:
- The test substance was considered as not carcinogenic in B6C3F1 mice.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- < 250 ppm
- Sex:
- male/female
- Basis for effect level:
- other: Decrease of body weight gain was observed at 250 and 500 ppm in mice.
- Remarks on result:
- other: Systemic toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- > 500 ppm
- Sex:
- male/female
- Basis for effect level:
- other: No tumors was observed in mice after exposure of 250 and 500 ppm of DETU during 103 weeks.
- Remarks on result:
- other: carcinogenicity
Any other information on results incl. tables
Tables of results: Carcinogenicity study in mice with DETU
1/ Analyses of the incidence of primary tumors at specific sites in female mice treated with DETU
Topography: morphology |
control |
Low dose (250 ppm) |
High dose (500 ppm) |
Hematopoietic system : Leukemia or malignant lymphoma weeks to first observed tumor |
8/19 (42%)
93 |
15/48 (31%)
78 |
9/41 (22%)
92 |
Uterus: Endometrial stromal polyp weeks to first observed tumor |
0/17 (0%) / |
3/45 (7%) 62 |
2/38 (5%) 91 |
2/ Analyses of the incidence of primary tumors at specific sites in male mice treated with DETU
Topography: morphology |
control |
Low dose (250 ppm) |
High dose (500 ppm) |
Lung: Alveolar/Bronchiloar adenoma or alveolar/bronchiolar carcinoma weeks to first observed tumor |
2/13 (15%)
99 |
4/46 (9%)
104 |
6/46 (13%)
99 |
Hematopoietic system : Leukemia or malignant lymphoma weeks to first observed tumor |
3/15 (20%)
93 |
11/48 (23%)
90 |
12/49 (24%)
76 |
Circulatory system: Hemangioma or hemangiosarcoma weeks to first observed tumor |
1/15 (7%)
104 |
1/48 (2%)
104 |
3/49 (6%)
99 |
Liver: Hepatocellular carcinoma weeks to first observed tumor |
2/14 (14%) 104 |
5/48 (10%) 71 |
2/49 (4%) 104 |
Liver: Hepatocellular carcinoma or hepatocellular adenoma weeks to first observed tumor |
5/14 (36%)*
/ |
7/48 (15%)
104 |
3/49 (6%)*
91 |
* Significative difference between treated and control groups (cochran-Armitage est supported by a Fischer exact test)
Applicant's summary and conclusion
- Executive summary:
Study was performed to determine whether DETU have the capacity to produce cancer in animals.
Mice were exposed to DETU in diet during 103 weeks at 250 and 500 ppm (12.5 and 25 mg/kg bw/d respectively).
No mortality, no clinical signs were observed during this study, but decrease of body weight gain was observed at each dose.
In both sexes, the neoplasms observed were similar in type and distribution in dosed and control mice (ex: alveolar/bronchiolar adenoma, hepatocellular adenoma and carcinoma, leukemia or malignant lymphoma...). None of statistical tests for any site revealed a significant positive association between administration of compound and increased tumor incidence.
The severity and incidence of non-neoplastic lesions were also not unusual (ex: pneumonia, spleen hyperplasia...).
The test substance was considered as not carcinogenic in B6C3F1 mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
